ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,149.77
0.04%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,319.59
-0.58%
Brent Oil
82.495
0.45%
Bitcoin
66,155.73
-0.73%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. BetterLife Pharma Inc (QB) (BETRF)

  7. BetterLife Pharma Inc (QB) (BETRF) News

BetterLife Pharma (QB) (BETRF)

BetterLife Pharma Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BETRF
DateTimeSourceHeadlineSymbolCompany
14/05/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
06/05/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
05/03/202420:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
02/01/202418:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
29/12/202319:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
18/12/202317:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
30/11/202318:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
29/09/202318:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
28/09/202314:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
05/09/202315:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
13/07/202316:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
28/06/202322:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
28/06/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
28/06/202322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
09/06/202321:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
06/06/202321:23Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:BETRFBetterLife Pharma Inc (QB)
10/05/202314:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
25/04/202318:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
08/03/202319:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
07/03/202321:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
28/02/202314:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
18/01/202314:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
23/12/202214:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
08/12/202213:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
08/11/202222:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
27/09/202221:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
29/06/202218:22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
06/06/202219:35Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
01/06/202211:00Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
04/03/202218:21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:BETRF

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
SDRY
Superdry
LSE
LBE
Longboat Energy
LSE
GKP
Gulf Keystone Petroleum
LSE
PANR
Pantheon Resources
LSE
TERN
Tern
LSE
THG
Thg
LSE
HE1
Helium One Global
LSE
POS
Plexus
LSE
ENET
Ethernity Networks
LSE
RKH
Rockhopper Exploration
LSE
VAST
Vast Resources
LSE
EEE
Empire Metals
LSE
KEFI
Kefi Gold And Copper
LSE
BIRD
Blackbird
LSE
CGO
Contango
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved